I'm going to agree wholeheartedly with your position PG! As a business owner, when you, the owner of the company has a positive position regarding news that affects your company, regardless of the field, whether you're a plumbing contractor ( ;-) ) or a biotech firm, planning for the next step is imminent when positive news is learned. Too many people and firms are affected by approvals to keep a lid on this type of news. In my estimation in regards to positive results regarding the FDA, as PG noted before, dont be surprised if there is another round of questioning, but, its almost certain that BMSN and Regen are a shoe in for at least phase I/II clinical trials. As has been stated before, this is a LONG TERM play, Flippers and traders will gloat over there 2 tick gain for the day for peanuts. Me personally, as i have stated before, am playing this bad boy out for a end game result! Money and a cure! BMSN.
Also its imperative that investors read up on Autologous stem cell therapy. What's the biggest problem we as humans face with transplants? Rejection by your body of the donor organ. with Autologous stem cell therapy rejection of your own stem cells is not going to happen, thus you have a safe therapy that doesn't take a lifetime of medication to keep the transplant in check! WIn/Win!
Now couple this with the siRNA gene silencing science, holy snap! This is cutting edge shiot and you the reader have invested in it! Way too much good stuff in the pipeline to not want to ride this baby out!
